Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP0DV
|
||||
Drug Name |
4-(2-cyclohexylethyl)-23-oxo-8-oxa-1,15,17,21-tetraazapentacyclo[19.2.2.13,7.19,13.015,19]heptacosa-3(27),4,6,9(26),10,12,16,18-octaen-10-yl cyanide
|
||||
Synonyms |
CHEMBL159171
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C31H35N5O2
|
||||
Canonical SMILES |
O=C1CN2CCN1Cc3cc(Oc4cc(Cn5cncc5C2)ccc4C#N)ccc3CCC6CCCCC6
|
||||
InChI |
InChI=1S/C31H35N5O2/c32-16-26-9-7-24-14-30(26)38-29-11-10-25(8-6-23-4-2-1-3-5-23)27(15-29)19-35-13-12-34(21-31(35)37)20-28-17-33-22-36(28)18-24/h7,9-11,14-15,17,22-23H,1-6,8,12-13,18-21H2
|
||||
InChIKey |
YIZSZHVXFHAUCR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.